Medicover Ab Class B · OMXSTO:MCOV_B

Medicover Ab Class B — Merger or Acquisition (August 2026)

8 slides from Medicover Ab Class B's merger presentation, Aug 6, 2026

  1. Slide 1: Divestment of Medicover Hospitals India

    Divestment of Medicover Hospitals India John Stubbington, CEO Anand Patel, CFO 6 AUGUST 2026

  2. Slide 2: Disclaimer Regarding Forward-Looking Statements

    DISCLAIMER REGARDING FORWARD-LOOKING STATEMENTS This presentation may contain certain forward-looking statements and opinions. Forward-looking statements are statements that do not relate to historical facts and events and such statements and opinions pertaining to the future that, by example, conta

  3. Slide 3: Transaction highlights

    Transaction highlights Transaction ▪ Medicover and local partners to dispose 100% of equity capital in Medicover Hospitals India (”MHI”) to structure and funds managed by global investment firm KKR (”KKR”) for a purchase price of INR 105.0bn (EUR valuation ~0.95bn), to be paid at closing in one inst

  4. Slide 4: Financial profile strengthened by MHI divestment

    Financial profile strengthened by MHI divestment • Clear value realisation: Strong interest in Financial Medicover Medicover MHI validated its IPO-quality profile, with a MHI Metrics (EURm, Group Group ex. MHI 100% cash sale delivering immediate value (indicative) LTM Q2 2026) (as reported) (illustr

  5. Slide 5: A more focused Medicover with continued balanced profile

    A more focused Medicover with continued balanced profile Revenue and profitability Revenue mix Revenue mix By geography, as of Q2 2026 By payer, as of Q2 2026 2500 2,378 30% 25% 9% 20% 2000 1,510 20% 10% 1500 14.4% 15.6% 15% 13% 53% 1000 10% 60% 20% Before 500 5% 15% 0 0% 2022 2025 Revenue EBITDA ma

  6. Slide 6: Key takeaways

    Key takeaways ▪ Attractive MHI exit: Medicover monetises the value of its India investment at compelling terms and with greater Revenue growth certainty than an IPO ▪ Stronger balance sheet: The expected proceeds from the transaction would materially strengthen Medicover’s EBITDA margin liquidity po

  7. Slide 7: Medicover

    | \ a > ~ aa MEDICOVER Sf ff

  8. Slide 8: End

    | \ ry: =

Medicover — Merger or Acquisition (August 2026) on 6ix